Page 81 - GPD-2-2

Gene & Protein in Disease Genetics of arteriovenous malformations

arteriovenous malformation mouse models for Type 1 vascular malformations that require MEK but not PI3K
hereditary hemorrhagic telangiectasia. PLoS One, 9(2): signaling. Circ Res, 127(6): 727–743.
e88511.
https://doi.org/10.1161/CIRCRESAHA.119.316500
https://doi.org/10.1371/journal.pone.0088511
70. Oka M, Kushamae M, Aoki T, et al., 2019, KRAS G12D
60. Rossi E, Bernabeu C, Smadja DM, 2019, Endoglin as an or G12V mutation in human brain arteriovenous
adhesion molecule in mature and progenitor endothelial malformations. World Neurosurg, 126: e1365–e1373.
cells: A function beyond TGF-β. Front Med, 6: 10.
https://doi.org/10.1016/j.wneu.2019.03.105
https://doi.org/10.3389/fmed.2019.00010
71. Al-Olabi L, Polubothu S, Dowsett K, et al., 2018, Mosaic
61. Wooderchak-Donahue WL, McDonald J, O’Fallon B, et al., RAS/MAPK variants cause sporadic vascular malformations
2013, BMP9 mutations cause a vascular-anomaly syndrome which respond to targeted therapy. J Clin Invest, 128(4):
with phenotypic overlap with hereditary hemorrhagic 1496–1508.
telangiectasia. Am J Hum Genet, 93(3): 530–537.
https://doi.org/10.1172/JCI98589
https://doi.org/10.1016/j.ajhg.2013.07.004
72. Priemer DS, Vortmeyer AO, Zhang S, et al., 2019, Activating
62. Hodgson J, Ruiz-Llorente L, McDonald J, et al., 2021, KRAS mutations in arteriovenous malformations of the
Homozygous GDF2 nonsense mutations result in a loss of brain: Frequency and clinicopathologic correlation. Hum
circulating BMP9 and BMP10 and are associated with either Pathol, 89: 33–39.
PAH or an “HHT‐like” syndrome in children. Mol Genet
Genomic Med, 9(12): e1685. https://doi.org/10.1016/j.humpath.2019.04.004
https://doi.org/10.1002/mgg3.1685 73. Hong T, Yan Y, Li J, et al., 2019, High prevalence of
KRAS/BRAF somatic mutations in brain and spinal cord
63. Balachandar S, Graves TJ, Shimonty A, et al., 2022, arteriovenous malformations. Brain, 142(1): 23–34.
Identification and validation of a novel pathogenic variant
in GDF2 (BMP9) responsible for hereditary hemorrhagic https://doi.org/10.1093/brain/awy307
telangiectasia and pulmonary arteriovenous malformations. 74. McCubrey JA, Steelman LS, Chappell WH, et al., 2007, Roles
Am J Med Genet A, 188(3): 959–964. of the Raf/MEK/ERK pathway in cell growth, malignant
https://doi.org/10.1002/ajmg.a.62584 transformation and drug resistance. Biochim Biophys Acta,
1773(8): 1263–1284.
64. Farhan A, Yuan F, Partan E, et al., 2022, Clinical
manifestations of patients with GDF2 mutations associated https://doi.org/10.1016/j.bbamcr.2006.10.001
with hereditary hemorrhagic telangiectasia Type 5. Am J 75. Whitehead KJ, Smith MCP, Li DY, 2013, Arteriovenous
Med Genet A, 188(1): 199–209. malformations and other vascular malformation syndromes.
https://doi.org/10.1002/ajmg.a.62522 Cold Spring Harb Perspect Med, 3(2): a006635–a006635.
65. Gallione CJ, Richards JA, Letteboer TGW, et al., 2006, https://doi.org/10.1101/cshperspect.a006635
SMAD4 mutations found in unselected HHT patients. 76. Mouchtouris N, Jabbour PM, Starke RM, et al., 2015, Biology
J Med Genet, 43(10): 793–797. of cerebral arteriovenous malformations with a focus on
https://doi.org/10.1136/jmg.2006.041517 inflammation. J Cereb Blood Flow Metab, 35(2): 167–175.
66. Wain KE, Ellingson MS, McDonald J, et al., 2014, Appreciating https://doi.org/10.1038/jcbfm.2014.179
the broad clinical features of SMAD4 mutation carriers: 77. Sturiale CL, Puca A, Sebastiani P, et al., 2013, Single
A multicenter chart review. Genet Med, 16(8): 588–593. nucleotide polymorphisms associated with sporadic brain
https://doi.org/10.1038/gim.2014.5 arteriovenous malformations: Where do we stand? Brain,
136(2): 665–681.
67. Steiger HJ, 2021, Recent progress understanding
pathophysiology and genesis of brain AVM-a narrative https://doi.org/10.1093/brain/aws180
review. Neurosurg Rev, 44(6): 3165–3175. 78. Rosenberg GA, 2002, Matrix metalloproteinases in
https://doi.org/10.1007/s10143-021-01526-0 neuroinflammation. Glia, 39(3): 279–291.
68. Nikolaev SI, Vetiska S, Bonilla X, et al., 2018, Somatic https://doi.org/10.1002/glia.10108
activating KRAS mutations in arteriovenous malformations 79. Li H, Nam Y, Huo R, et al., 2021, De novo germline and
of the brain. N Engl J Med, 378(3): 250–261.
somatic variants convergently promote endothelial-to-
https://doi.org/10.1056/NEJMoa1709449 mesenchymal transition in simplex brain arteriovenous
malformation. Circ Res, 129(9): 825–839.
69. Fish JE, Suarez CPF, Boudreau E, et al., 2020, Somatic gain
of KRAS function in the endothelium is sufficient to cause https://doi.org/10.1161/CIRCRESAHA.121.319004

Volume 2 Issue 2 (2023) 15 https://doi.org/10.36922/gpd.0312